EMERYVILLE, Calif., April 8, 2013 /PRNewswire/ -- MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Ping Zhang , Ph.D. has been appointed senior vice president of product innovation and chief technology officer.
Dr. Zhang has provided engineering leadership for a wide variety of organizations, ranging from startups to some of the world's best-known technology companies. Most recently, he was the senior vice president of research & development for Epocrates, Inc., a mobile and cloud-based health pioneer widely recognized for developing the most popular point-of-care medical applications used by physicians. Prior to Epocrates, he held executive leadership positions for Harris Corporation, Carefx Corporation, QuadraMed Corporation, and Siemens.
"We are delighted to have someone of Ping's caliber join MedeAnalytics at this important time," said MedeAnalytics Chief Executive Officer Mike Gallagher . "We look forward to benefiting from his extensive experience in healthcare, technology, mobility and product innovation to drive our future development efforts."
"MedeAnalytics has a well-deserved reputation for having a world-class and cloud-based analytics platform dedicated to healthcare providers and payers," said Zhang. "I am very excited to be part of such a leading organization, helping make a difference in transforming healthcare."
Zhang earned his bachelor's degree at the age of 19 in China. He holds both a Master of Science degree and a Ph.D. degree from the University of Arkansas at Fayetteville.
Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.For more information:
MedeAnalytics, Inc.Gary Summers
5858 Horton Street, Suite 475 Lewis & Summers Public Relations
Emeryville, CA 94608 (925) firstname.lastname@example.org
Copyright©2012 PR Newswire.
All rights reserved